04:32 AM EDT, 03/20/2026 (MT Newswires) -- Bobak R. Azamian, Director, President, Chief Executive Officer and Board Chair, on March 17, 2026, sold 34,603 shares in Tarsus Pharmaceuticals ( TARS ) for $2,364,904. Following the Form 4 filing with the SEC, Azamian has control over a total of 891,412 common shares of the company, with 33,421 shares held directly and 857,991 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1819790/000182767226000007/xslF345X05/wk-form4_1773961418.xml